HYDROGELPFLASTER

European patent · EP3449913 · In force

Register entry

Publication number
EP3449913
Application number
EP18766653
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 14, 2018
Published
Mar 6, 2019
Granted
Apr 26, 2023
Protection ends at the latest
Mar 13, 2038
Next annual fee due
Mar 31, 2027
IPC classes
A61L 27/26 (2006.01)
A61L 27/52 (2006.01)
A61L 27/54 (2006.01)
A61L 27/56 (2006.01)
A61P 25/00 (2006.01)
A61K 31/728 (2006.01)
A61K 38/18 (2006.01)
A61K 38/36 (2006.01)
A61K 38/39 (2006.01)
A61L 27/20 (2006.01)
A61L 27/22 (2006.01)
Priority
KR 20170032019 14.03.2017
PCT application
PCT/KR2018/003011 14.03.2018
PCT publication
WO2018/169314 20.09.2018
Filing language
Korean
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Mar 6, 2024

    Change

    Published in Swissreg on 06.03.2024

  5. May 5, 2023

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 05.05.2023

  6. Apr 26, 2023

    Granted

    Published in Swissreg on 26.04.2023

Parties

Holder

Supine Therapeutics Co., Ltd.

105-220, 50, UNIST-gil Eonyang-eup, Ulju-gun, Ulsan 44919, KR

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

KIM, Jeong Beom

Ulju-gun Ulsan 44919, KR

NAM, Dong Gyu

Ulju-gun, Ulsan 44919, KR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.